Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00610129
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:04.347293+00:00
Published At
2015-11-20T00:00:00+00:00
Record Updated At
2015-11-20
Results Posted At
2015-11-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neuroendocrine Tumors", "Metastatic Neuroendocrine Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-11-20"
protocolSection.identificationModule.nctId
"NCT00610129"
protocolSection.identificationModule.officialTitle
"A Phase II Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-11-20"

Study condition terms

  • Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)
  • Metastatic Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.